It’s been a long time coming, but Canada’s Liberal government is expected to announce plans next month to legalize cannabis in the country. According to CBC News, the announcement will be made the week of April 10, and the goal will be to legalize marijuana by July 1, 2018.
Other publications have suggested that the news will be released on different dates. The Globe and Mail says it will come on April 20, or 4/20, while in a statement to Global News, Justice Minister Jody-Wilson-Raybould said that legalization will be introduced this spring, but didn’t provide a specific date.
“Our government is committed to introducing legislation this spring that would, as promised, legalize, strictly regulate, and restrict access to cannabis,” Wilson-Raybould said. “In order to meet our commitment to legalize, the legislation will need to pass through the parliamentary process in a timely fashion.”


While it may be over a year until marijuana is officially legalized, a report released last year by Canada’s Task Force on Cannabis Legalization and Regulation has already made 80 recommendations for framing legalization effectively.
Among other things, the report recommends that the federal government use licensing and production controls and enforce a minimum purchasing age of 18. Provincial governments will manage distribution and pricing, and will have the authority to set a higher minimum purchasing age.
Households will be able to grow up to four plants, says CBC News.
The news outlet’s report came the same day as the NDP met in Montreal for a leadership debate. At the event, party members criticized the Liberal government’s “promise to legalize pot,” says Global News.
“I believe in legalization,” BC MP Peter Julian was quoted as saying. “I do not believe Justin Trudeau is going to bring in the legalization of marijuana and as proof that … we are still seeing, particularly young Canadians, being criminalized by simple possession of marijuana.”

Canadian cannabis stocks have performed well following the news that legalization is impending. Gainers include:
  • Canopy Growth (TSX:WEED) — up 9.11 percent at $10.79
  • Aurora Cannabis (TSXV:ACB) — up 8.33 percent at $2.48
  • Tetra Bio-Pharma (CNSX:TBP) — up 9.37 percent at $0.70
  • Emblem (TSXV:EMC) — up 4.7 percent at $2.45
  • Maple Leaf Green World (TSXV:MGW) — up 7.69 percent at $0.55

Don’t forget to follow us @INN_Resource for real-time news updates!
Securities Disclosure: I, Jocelyn Aspa, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Maple Leaf Green World is a client of the Investing News Network. This article is not paid-for content.


Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less